SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
cholesterol
cholesterol
International
Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
By
James Paton
and
Bloomberg
November 25, 2019
Health
Why Amgen Is Lowering the Price of Cholesterol Drug Repatha By 60%
By
Lucas Laursen
October 25, 2018
Health
Could a Vaccine Prevent High Cholesterol and Heart Disease?
By
Sy Mukherjee
June 20, 2017
Health
There Is No Reason to Even Consider Eating Reduced Fat Cheese, Says Science
By
Danica Lo
and
Food & Wine
September 21, 2016
Health
Another Major Insurer Is Tying Drug Prices to Health Outcomes
By
Sy Mukherjee
May 11, 2016
Health
Amgen Just Won a Major Drug Patent Case Against Its Rivals
By
Sy Mukherjee
March 16, 2016
Most Popular
North America
'The frustration is overwhelming': Soybean farmers feel betrayed as Argentina blows a hole in rural America’s $47...
By
Sasha Rogelberg
Success
Gen Z is reviving this boring job that millennials and boomers abandoned—and it's helping them land six-figure careers...
By
Preston Fore
Investing
Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for US consumers,’...
By
Jim Edwards